)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Tenon Medical
Tenon Medical (TNON) investor relations material
Tenon Medical Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary22 Jun, 2026
Company overview and business model
Focuses on minimally invasive medical devices for sacroiliac (SI) joint disorders, offering Catamaran and SImmetry SI Joint Fusion Systems for surgical treatment of lower back pain.
Catamaran System received FDA clearance in 2018 and launched nationally in October 2022, targeting primary, revision, and adjunct SI joint procedures.
Acquired assets from SiVantage and SIMPL Medical in August 2025, expanding its product portfolio and market reach.
Emphasizes innovation with proprietary implant designs and clinical protocols to improve outcomes and adoption.
Financial performance and metrics
Raised approximately $2.85 million in gross proceeds from a private placement in November 2025.
As of June 17, 2026, 11,849,674 shares of common stock were outstanding, with potential for significant dilution from warrants, options, and convertible securities.
Financial statements for 2024 and 2025 include a going concern warning from auditors.
Use of proceeds and capital allocation
Will not receive proceeds from resale of shares by selling stockholders; proceeds from warrant exercises will be used for working capital and general corporate purposes.
Management retains broad discretion over allocation of any proceeds from warrant exercises.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tenon Medical
- Shareholders will vote on director elections, a reverse stock split, and key financing approvals.TNON
Proxy filing12 Jun 2026 - Q1 2026 revenue up 90% to $1.4M, gross margin 68.5%, net loss narrowed, liquidity risks remain.TNONQ1 202615 May 2026
- Record revenue, margin gains, and new product launches drive growth and improved financials.TNONQ4 202520 Mar 2026
- Q2 revenue up 21%, gross margin at 52%, but going concern risk remains.TNONQ2 20241 Feb 2026
- Innovative SI joint fusion tech shows strong results and expands with new miniaturized platform.TNONMaxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026
- Q3 revenue fell 6% but gross margin improved; liquidity remains a key concern despite equity raise.TNONQ3 202414 Jan 2026
- 2024 revenue up 12%, gross margin at 52%, and Catamaran SE launch set for mid-2025.TNONQ4 202424 Dec 2025
- Registering 5.4M shares for resale after $2.85M raise, with dilution and market risks ahead.TNONRegistration Filing16 Dec 2025
- Annual Meeting to vote on directors, equity plan, preferred stock, and auditor ratification.TNONProxy Filing2 Dec 2025
Next Tenon Medical earnings date
Q2 202612 Aug, 2026
Tenon Medical
Next Tenon Medical earnings date
Q2 202612 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage